3. Respiratory System
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
| Recommended in both primary and secondary care | Alternatives (often in specific conditions) in both primary and secondary care; | Where a specialist input is needed (see introduction for definition) | Prescribing principally within secondary care only |
- Guidance on inhaler devices and Nebulised therapy
- COPD Self–Management – Patients at risk of an exacerbation
- 3.1.1 Adrenoceptor agonists
- 3.1.2 Anitmuscarinic bronchodilators
- 3.1.3 Theophylline
- 3.1.4 Compound bronchodilator preparations
- 3.1.5 Peak flow meters, inhaler devices and nebulisers
- Corticosteroid licensed age indications and beclometasone diproprionate equivalence
- 3.2 Corticosteroids
- 3.3.2 Leokotriene receptor antagonist
- 3.4.1 Antihistamines
- 3.4.2 Allergen Immunotherapy
- 3.4.3 Allergic emergencies
- 3.5.1 Respiratory stimulents
- 3.5.2 Pulmonary surfactants
- 3.6 Oxygen
- 3.7 Mucolytics
- 3.8 Aromatic inhalations
- 3.9.1 Cough suppressants
- 3.9.2 Expectorant & demulcent cough preparations
- 3.10 Systemic nasal decongestants
Appendices
- Appendix 1 British guidelines on the management of asthma
- Appendix 2 Management of COPD
- Appendix 3 Home oxygen therapy service
- COPD Rescue Pack Doxycycline Leaflet
- COPD Rescue Pack Information Leaflet Amoxicillin
- COPD Self Management Plan
- Corticosteroid license equivalence
Last updated by: Carol Webb on 18-04-2012 15:12
Please click on the links below for more information
-
BNF
-
NICE
-
Summary of product characteristics
